Abstract:The human growth hormone 1 (HGH1), a protein-coding gene, plays a crucial role in human growth and development. However, its role in human cancer remains unclear. For the first time, this study comprehensively evaluated the potential involvement of HGH1 in cancer prognosis and immunological function. To achieve this, data from various databases, including The Cancer Genome Atlas, Genotype Tissue Expression, Cancer Cell Lineage Encyclopedia, Human Protein Atlas, cBioPortal, Tumor Immune Estimation Resource and Immune Cell Abundance Identifier, were collated, as well as from one large clinical study, three immunotherapy cohorts and in vitro experiments. This study aims to elucidate the role of HGH1 expression in cancer prognosis and immune response. Our findings revealed a significant association between increased HGH1 expression and a worse prognosis across various cancer types. Predominantly, copy number variations were identified as the most common genetic mutations. Additionally, HGH1 was observed to not only regulate cell cycle-related functions to promote cell proliferation but also influence autoimmunity-related functions within both the innate and adaptive immune systems, along with other relevant immune-related signaling pathways. Gene set enrichment analysis and gene set variation analysis were used to substantiate these findings. HGH1 overexpression contributed to an immune-deficient (immune-desert) tumor microenvironment, which was characterized by a significant expression of immune-related features such as immune-related gene and pathway expression and the number of immune-infiltrating cells. Furthermore, the correlation between HGH1 expression and tumor mutational burden in four cancers and microsatellite instability in eight cancers was observed. This suggests that HGH1 has potential as an immunotherapeutic target. Immunotherapy data analysis supports this notion, demonstrating that patients with low HGH1 expression treated with immune checkpoint inhibitors exhibit improved survival rates and a higher likelihood of responding to immunotherapy than patients with high HGH1 expression. Collectively, these findings highlight the significant role of HGH1 in human cancers, illuminating its involvement in tumorigenesis and cancer immunity. Elevated HGH1 expression was identified to be indicative of an immune-desert tumor microenvironment. Consequently, the targeting of HGH1, particularly in combination with immune checkpoint inhibitor therapy, holds promise for enhancing therapeutic outcomes in patients with cancer.

Interactome Study Suggests Multiple Cellular Functions of Hepatoma-Derived Growth Factor (HDGF)

Role of Hepatoma‐derived Growth Factor in Promoting De Novo Lipogenesis and Tumorigenesis in Hepatocellular Carcinoma

Relationship of HDGF or VEGF expression with hepatocellular carcinoma angiogenesis:report of 108 cases

HAP40 is a conserved central regulator of Huntingtin and a specific modulator of mutant Huntingtin toxicity

HDGF: a Novel Jack-of-all-trades in Cancer.

Expression and Function of Hepatocyte Growth Factor Activator Inhibitor Type 1

Prognostic role of hepatoma-derived growth factor in solid tumors of Eastern Asia: a systematic review and meta- analysis.

HDGF-related protein-3 is required for anchorage-independent survival and chemoresistance in hepatocellular carcinomas.

Identification of Hepatopoietin Dimerization, Its Interacting Regions and Alternative Splicing of Its Transcription.

Clinical and Biological Significance of Hepatoma-Derived Growth Factor in Ewing's Sarcoma.

Hepatoma‐derived Growth Factor Involved in the Carcinogenesis of Gastric Epithelial Cells Through Promotion of Cell Proliferation by Erk1/2 Activation

Downregulated Expression of Hepatoma-Derived Growth Factor (HDGF) Reduces Gallbladder Cancer Cell Proliferation and Invasion

HDGF-related Protein-2 (HRP-2) Acts As an Oncogene to Promote Cell Growth in Hepatocellular Carcinoma.

Peptide identification of hepatocyte growth-promoting factor and its function in cytoprotection and promotion of liver cell proliferation through the JAK2/STAT3/c-MYC pathway

Binding Behavior of Human Hepatoma-Derived Growth Factor on SMYD1

Hepatopoietin Acts As an Autocrine Growth Factor in Hepatoma Cells

Downregulated Expression Of Hepatomaderived Growth Factor Inhibits Migration And Invasion Of Prostate Cancer Cells By Suppressing Epithelial- Mesenchymal Transition And Mmp2, Mmp9

Stimulation of the Mitogen-activated Protein Kinase Cascade and Tyrosine Phosphorylation of the Epidermal Growth Factor Receptor by Hepatopoietin*

Effect of Hesperidin on TGF-beta1/Smad Signaling Pathway in HSC.

Proteomic Dissection of Cell Type-Specific H2AX-interacting Protein Complex Associated with Hepatocellular Carcinoma.

HGH1 and the immune landscape: a novel prognostic marker for immune-desert tumor microenvironment identification and immunotherapy outcome prediction in human cancers